References
- Cramer HB, Kartush JM. Testing facial nerve function. Otolaryngol Clin North Am. 1991;24:555–570.
- May M. Facial nerve paralysis. In: Paparella MM, Shumrick DA, editors. Otolaryngology. Philadelphia (PA): WB Saunders Co; 1991. p. 1097–1136.
- Yanilmaz M, Akduman D, Sagun ÖF, et al. The effects of aminoguanidine, methylprednisolone, and melatonin on nerve recovery in peripheral facial nerve neurorraphy. J Craniofac Surg. 2015;26:667–672.
- Bast A, Haenen GRMM. Lipoic acid: a multifunctional nutraceutical. In: Kramer K, Hope PP, Packer L, editors. Nutraceuticals in health and disease prevention. New York (NY): Marcel Dekker Inc; 2001. p. 113–128.
- Bharat S, Cochran BC, Hsu M, et al. Pre-treatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 cells: implications for Parkinson's disease therapy. Neurotoxicology. 2002;23:479–486.
- Sullivan FM, Swan IR, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med. 2007;357:1598–1607.
- Topaloglu I, Bal M. Electrophyslogic and histopathologic evaluation of normal and high dose corticosteroid treatment on nerve healing in rats with traumatic facial paralysis. Paper presented at 34th Turkish National Otorhinolaryngology Congress Book; 2012.
- Hoshida S, Hatano M, Furukawa M, et al. Neuroprotective effects of vitamin E on adult rat motor neurones following facial nerve avulsion. Acta Otolaryngol. 2009;129:330–336.
- Al-Bishri A, Dahlin L, Sunzel B, et al. Systemic betamethasone accelerates functional recovery after a crush injury tor at sciatic nerve. J Oral Maxillofac Surg. 2005;63:973–977.
- Myckatyn TM, Mackinnon SE. The surgical management of facial nerve injury. Clin Plast Surg. 2003;30:307–318.
- Suzuki YJ, Tsuchiya M, Packer L. Antioxidant activities of dihydrolipoic acid and its structural homologues. Free Radic Res Commun. 1993;18:115–122.
- Biewenga G, Haenen GR, Bast A. The role of lipoic acid in the treatment of diabetic polyneuropathy. Drug Metab Rev. 1997;29:1025–1054.
- Zhang WJ, Wei H, Hagen T, et al. Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc Natl Acad Sci USA. 2007;104:4077–4082.
- Foster TS. Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy. Diabetes Educ. 2007;33:111–117.
- Bilska A, Wlodek L. Lipoic acid – the drug of the future? Pharmacol Rep. 2005;57:570–577.
- Glantzounis GK, Yang W, Koti RS, et al. The role of thiols in liver ischemia-reperfusion injury. Curr Pharm Des. 2006;12:2891–2901.
- Freitas RM. The evaluation of effects of lipoic acid on the lipid peroxidation, nitrite formation and antioxidant enzymes in the hippocampus of rats after pilocarpine-induced seizures. Neurosci Lett. 2009;455:140–144.
- Senoğlu M, Nacitarhan V, Kurutas EB, et al. Intraperitoneal alpha-lipoic acid to prevent neural damage after crush injury to the rat sciatic nerve. J Brachial Plex Peripher Nerve Inj. 2009;4:22.
- Foecking EM, Fargo KN, Coughlin LM, et al. Single session of brief electrical stimulations immediately following crush injury enhances functional recovery of rat facial nerve. J Rehabil Res Dev. 2012;49:451–458.
- Headlock T, Kowaleski J, Lo D, et al. Functional assessments of the rodent facial nerve: a synkinesis model. Laryngoscope. 2008;118:1744–1749.